prodcode,dmdcode,gemscriptcode,therapyevents,productname,ingredient,strength,formulation,routeofadministration,bnftext,v12,v13,v14,v15,v16,v17,v18,v19,v20,v21,slashcountinchapter,bnfchapter
30447,4832511000001106,76774020,22,Synagis 50mg powder and solvent for solution for injection vials (AbbVie Ltd),Palivizumab,50mg,Powder and solvent for solution for injection,Intramuscular,Respiratory Syncytial Virus,February 2009,7640001,,,,,,,,,0,5030500
65336,3.03191110000e+16,54187021,6,Palivizumab 100mg/1ml solution for injection vials,Palivizumab,100mg/1ml,Solution for injection,Intramuscular,Respiratory Syncytial Virus,January 2016,54187021,,,,,,,,,0,5030500
54688,1.57749110000e+16,36581020,2,Ribavirin 1.2g/12ml solution for injection vials,Ribavirin,100mg/1ml,Solution for injection,Intravenous,Chronic Hepatitis C/Respiratory Syncytial Virus,April 2013,36581020,,,,,,,,,1,5030500
65420,3.02513110000e+16,54190021,2,Synagis 50mg/0.5ml solution for injection vials (AbbVie Ltd),Palivizumab,100mg/1ml,Solution for injection,Intramuscular,Respiratory Syncytial Virus,February 2016,54190021,,,,,,,,,0,5030500
21704,4831711000001108,76775020,52,Synagis 100mg powder and solvent for solution for injection vials (AbbVie Ltd),Palivizumab,100mg,Powder and solvent for solution for injection,Intramuscular,Respiratory Syncytial Virus,February 2009,7640002,,,,,,,,,0,5030500
